Airway diseases
Interstitial lung diseases
Pulmonary vascular diseases
Thoracic oncology
Oral presentation
From tobacco and vaping health effects to tobacco cessation
Abstracts presented in this session are also available as E-posters from 24 August 2020
Methods :
Physiology, Cell and molecular biology, Epidemiology, Public health, Palliative care
10:43
Late Breaking Abstract - Differences in flavorant levels and synthetic coolant use between USA, EU and Canadian Juul products
H. Erythropel(New Haven, United States)
COI
10:46
Treatment complication rates in continued smokers vs quitters after a diagnosis of lung cancer: a cohort study
R. Gemine(llanelli (Dyfed), United Kingdom)
COI
10:49
Flavor-solvent reaction products in electronic cigarette liquids activate respiratory irritant receptors and elicit cytotoxic metabolic responses in airway epithelial cell
S. Jordt(Durham, NC, United States)
COI
10:52
Outpatient smoking cessation: preliminary findings of a non-inferiority RCT comparing blended with face-to-face delivery mode
L. Siemer(Enschede, Netherlands)
COI
10:55
Asthma do not counteract smoking initiation
L. Hedman(Luleå, Sweden)
COI
10:58
Acute health effects after passive e-vape among patients with COPD – an RCT exposure study
K. Rosenkilde Laursen(Århus, Denmark)
COI
11:01
Evolution in disease severity during the E-cigarette or Vaping-Associated Lung Injury (EVALI) outbreak
M. Lanspa(Salt Lake City, United States)
COI
11:04
Association of low-intensity smoking with respiratory and lung cancer mortality
P. Balte(New York, United States)
COI
. . .
